Form 4 Filing for Altimmune, Inc. (ALT)

This filing details a transaction by John Gill, a director at Altimmune, Inc. On April 6, 2026, John Gill acquired 9,200 shares of the company's common stock through a purchase transaction. The shares were bought at a weighted average price of $3.4076 per share, with individual transaction prices ranging from $3.4050 to $3.4080. Following this acquisition, John Gill now beneficially owns 21,700 shares of Altimmune, Inc. common stock. The reporting person has undertaken to provide further details on the specific prices of each transaction upon request.